Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)

Background. Standard treatment for hormone-dependent operable breast cancer includes surgery, hormone therapy (HT), and radiation therapy and chemotherapy (when necessary). Some elderly patients do not undergo surgery because of the high risk or refuse to be operated on. In such case, the only possi...

Full description

Bibliographic Details
Main Authors: A. G. Manikhas, D. S. Pasekova
Format: Article
Language:Russian
Published: ABV-press 2021-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/841
_version_ 1797876037291343872
author A. G. Manikhas
D. S. Pasekova
author_facet A. G. Manikhas
D. S. Pasekova
author_sort A. G. Manikhas
collection DOAJ
description Background. Standard treatment for hormone-dependent operable breast cancer includes surgery, hormone therapy (HT), and radiation therapy and chemotherapy (when necessary). Some elderly patients do not undergo surgery because of the high risk or refuse to be operated on. In such case, the only possible option is conservative treatment with hormones (± radiotherapy).Objective: to compare progression-free survival, local relapse-free survival, and metastasis-free survival between elderly patients with hormone-dependent breast cancer receiving different treatments (surgery + HT vs HT alone).Materials and methods. This study included 60 patients with stage I–II hormone-dependent breast cancer aged 65 years and older. Thirty patients in the experimental group received HT only, while 30 patients in the control group received surgery + adjuvant HT. All patients were treated at Saint Petersburg Clinical Oncology Dispensary. Patients were followed up for 3 years.Results. During 3 years of the study, three women from the experimental group (10 %) were found to have local tumor growth despite treatment. Three patients in the control group (10 %) also had disease progression, but it was associated with the development of bone metastases.Conclusion. The conservative approach to treatment of early hormone-dependent breast cancer in elderly patients is a possible option in routine clinical practice; however, it requires the analysis of indications and identification of patients who will benefit from this approach.
first_indexed 2024-04-10T01:55:53Z
format Article
id doaj.art-db335559152b4128a4f23edc5d6631d5
institution Directory Open Access Journal
issn 1994-4098
1999-8627
language Russian
last_indexed 2024-04-10T01:55:53Z
publishDate 2021-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj.art-db335559152b4128a4f23edc5d6631d52023-03-13T08:44:37ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272021-09-0117210.17650/1994-4098-2021-17-2-32-38684Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)A. G. Manikhas0D. S. Pasekova1Кафедра радиологии, хирургии и онкологии ФГБУ «Российский научный центр радиологии и хирургических технологий им. акад. А. М. Гранова» Минздрава России; ГБУЗ «Санкт-Петербургский городской клинический онкологический диспансер»ГБУЗ «Санкт-Петербургский городской клинический онкологический диспансер»; кафедра онкологии ФПО ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава РоссииBackground. Standard treatment for hormone-dependent operable breast cancer includes surgery, hormone therapy (HT), and radiation therapy and chemotherapy (when necessary). Some elderly patients do not undergo surgery because of the high risk or refuse to be operated on. In such case, the only possible option is conservative treatment with hormones (± radiotherapy).Objective: to compare progression-free survival, local relapse-free survival, and metastasis-free survival between elderly patients with hormone-dependent breast cancer receiving different treatments (surgery + HT vs HT alone).Materials and methods. This study included 60 patients with stage I–II hormone-dependent breast cancer aged 65 years and older. Thirty patients in the experimental group received HT only, while 30 patients in the control group received surgery + adjuvant HT. All patients were treated at Saint Petersburg Clinical Oncology Dispensary. Patients were followed up for 3 years.Results. During 3 years of the study, three women from the experimental group (10 %) were found to have local tumor growth despite treatment. Three patients in the control group (10 %) also had disease progression, but it was associated with the development of bone metastases.Conclusion. The conservative approach to treatment of early hormone-dependent breast cancer in elderly patients is a possible option in routine clinical practice; however, it requires the analysis of indications and identification of patients who will benefit from this approach.https://ojrs.abvpress.ru/ojrs/article/view/841рак молочной железыпервичная гормонотерапияпожилые пациенткиконсервативное лечение
spellingShingle A. G. Manikhas
D. S. Pasekova
Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
Опухоли женской репродуктивной системы
рак молочной железы
первичная гормонотерапия
пожилые пациентки
консервативное лечение
title Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
title_full Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
title_fullStr Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
title_full_unstemmed Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
title_short Conservative treatment of early hormone-dependent breast cancer in elderly patients (65 years and older)
title_sort conservative treatment of early hormone dependent breast cancer in elderly patients 65 years and older
topic рак молочной железы
первичная гормонотерапия
пожилые пациентки
консервативное лечение
url https://ojrs.abvpress.ru/ojrs/article/view/841
work_keys_str_mv AT agmanikhas conservativetreatmentofearlyhormonedependentbreastcancerinelderlypatients65yearsandolder
AT dspasekova conservativetreatmentofearlyhormonedependentbreastcancerinelderlypatients65yearsandolder